ETI
DXCM icon

Enterprise Trust & Investment’s DexCom DXCM Stock Holding History

Enterprise Trust & Investment’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$2K Buy
+24
New +$2.19K ﹤0.01% 341

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Enterprise Trust & Investment's DXCM Position: Q2 2022 in Review

Enterprise Trust & Investment opened a new position in DexCom (DXCM) in Q2 2022: 24 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #341 among its holdings.

797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Enterprise Trust & Investment held 24 shares of DexCom worth $2K as of Q2 2022.
  • DexCom was a new Enterprise Trust & Investment position in Q2 2022.
  • DexCom made up ﹤0.01% of Enterprise Trust & Investment's portfolio in Q2 2022, its #341 holding.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.